VTV THERAPEUTICS INC- CL A (VTVT) Fundamental Analysis & Valuation

NASDAQ:VTVT • US9183852048

Current stock price

41.17 USD
+0.64 (+1.58%)
Last:

This VTVT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. VTVT Profitability Analysis

1.1 Basic Checks

  • VTVT had negative earnings in the past year.
  • VTVT had a negative operating cash flow in the past year.
  • In the past 5 years VTVT always reported negative net income.
  • In the past 5 years VTVT always reported negative operating cash flow.
VTVT Yearly Net Income VS EBIT VS OCF VS FCFVTVT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -10M -20M -30M -40M -50M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -30.00%, VTVT is in the better half of the industry, outperforming 66.92% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of -41.86%, VTVT is in the better half of the industry, outperforming 68.86% of the companies in the same industry.
Industry RankSector Rank
ROA -30%
ROE -41.86%
ROIC N/A
ROA(3y)-87.35%
ROA(5y)-74.14%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
VTVT Yearly ROA, ROE, ROICVTVT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -1K -2K -3K -4K -5K

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for VTVT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
VTVT Yearly Profit, Operating, Gross MarginsVTVT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -5K -10K -15K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. VTVT Health Analysis

2.1 Basic Checks

  • VTVT does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, VTVT has more shares outstanding
  • VTVT has less shares outstanding than it did 5 years ago.
  • VTVT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
VTVT Yearly Shares OutstandingVTVT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
VTVT Yearly Total Debt VS Total AssetsVTVT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M

2.2 Solvency

  • Based on the Altman-Z score of -1.36, we must say that VTVT is in the distress zone and has some risk of bankruptcy.
  • VTVT has a Altman-Z score of -1.36. This is comparable to the rest of the industry: VTVT outperforms 52.03% of its industry peers.
  • There is no outstanding debt for VTVT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -1.36
ROIC/WACCN/A
WACC9.21%
VTVT Yearly LT Debt VS Equity VS FCFVTVT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M -100M -150M

2.3 Liquidity

  • VTVT has a Current Ratio of 13.54. This indicates that VTVT is financially healthy and has no problem in meeting its short term obligations.
  • VTVT has a Current ratio of 13.54. This is amongst the best in the industry. VTVT outperforms 89.36% of its industry peers.
  • VTVT has a Quick Ratio of 13.54. This indicates that VTVT is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Quick ratio value of 13.54, VTVT belongs to the best of the industry, outperforming 89.36% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 13.54
Quick Ratio 13.54
VTVT Yearly Current Assets VS Current LiabilitesVTVT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. VTVT Growth Analysis

3.1 Past

  • The Earnings Per Share has been growing slightly by 1.98% over the past year.
  • The Revenue for VTVT has decreased by -100.00% in the past year. This is quite bad
EPS 1Y (TTM)1.98%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-5.45%
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-100%

3.2 Future

  • Based on estimates for the next years, VTVT will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.58% on average per year.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-21.3%
EPS Next 2Y-18.58%
EPS Next 3Y1.15%
EPS Next 5Y8.58%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
VTVT Yearly Revenue VS EstimatesVTVT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2024 2028 2029 2030 2031 2032 2033 200M 400M 600M
VTVT Yearly EPS VS EstimatesVTVT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 -50 -100

More info and screens

Find the best growth stocksShow best growing peers

0

4. VTVT Valuation Analysis

4.1 Price/Earnings Ratio

  • VTVT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year VTVT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
VTVT Price Earnings VS Forward Price EarningsVTVT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
VTVT Per share dataVTVT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-18.58%
EPS Next 3Y1.15%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. VTVT Dividend Analysis

5.1 Amount

  • No dividends for VTVT!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

VTVT Fundamentals: All Metrics, Ratios and Statistics

VTV THERAPEUTICS INC- CL A

NASDAQ:VTVT (4/2/2026, 8:00:52 PM)

41.17

+0.64 (+1.58%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)03-10
Earnings (Next)05-13
Inst Owners32.56%
Inst Owner Change29.31%
Ins Owners0.42%
Ins Owner Change0%
Market Cap162.21M
Revenue(TTM)N/A
Net Income(TTM)-26.97M
Analysts83.64
Price Target56.3 (36.75%)
Short Float %2.19%
Short Ratio1.53
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)19.85%
Min EPS beat(2)-8.04%
Max EPS beat(2)47.74%
EPS beat(4)2
Avg EPS beat(4)9.43%
Min EPS beat(4)-9.33%
Max EPS beat(4)47.74%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)7.81%
PT rev (3m)35.74%
EPS NQ rev (1m)28.61%
EPS NQ rev (3m)7.69%
EPS NY rev (1m)7.56%
EPS NY rev (3m)-6.43%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 2.52
P/tB 2.52
EV/EBITDA N/A
EPS(TTM)-3.35
EYN/A
EPS(NY)-4.06
Fwd EYN/A
FCF(TTM)-6.41
FCFYN/A
OCF(TTM)-6.41
OCFYN/A
SpS0
BVpS16.35
TBVpS16.35
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -30%
ROE -41.86%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-87.35%
ROA(5y)-74.14%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 13.54
Quick Ratio 13.54
Altman-Z -1.36
F-Score4
WACC9.21%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1.98%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-5.45%
EPS Next Y-21.3%
EPS Next 2Y-18.58%
EPS Next 3Y1.15%
EPS Next 5Y8.58%
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-100%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-35.68%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y0.21%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y0.21%
OCF growth 3YN/A
OCF growth 5YN/A

VTV THERAPEUTICS INC- CL A / VTVT Fundamental Analysis FAQ

What is the fundamental rating for VTVT stock?

ChartMill assigns a fundamental rating of 3 / 10 to VTVT.


What is the valuation status for VTVT stock?

ChartMill assigns a valuation rating of 0 / 10 to VTV THERAPEUTICS INC- CL A (VTVT). This can be considered as Overvalued.


What is the profitability of VTVT stock?

VTV THERAPEUTICS INC- CL A (VTVT) has a profitability rating of 1 / 10.


Can you provide the financial health for VTVT stock?

The financial health rating of VTV THERAPEUTICS INC- CL A (VTVT) is 7 / 10.